Radiation Enteritis
11
2
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
27%
3 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (11)
Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.
CMTS0515-auWMT for Radiation Enteritis
Preclinical Evaluation of Multimodal Therapeutic Strategies in Intestinal Irradiation and Inflammatory Bowel Disease From Organoids
Associations of Fecal Bile Acid Profile and Intestinal Flora With Chronic Radiation Enteritis
Fecal Microbiota Transplantation for Radiation Enteritis
A Study for Assessing the Efficacy and Safety of BH4 in Radiation Enteritis
Pentosan Polysulfate in Treating Patients With Gastrointestinal Disturbance Caused by Radiation Therapy
CAre of Patients With PArenteral Nutrition At Home
Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer
Therapy of Radiation Enteritis With Glutamine
Study to Prevent Radiation Induced Damage to Bowel Using a Prebiotic Enhanced Diet.